Denmark· DK-28106138318
Deferasirox "Stada"
A deferasirox product containing deferasirox, registered in Denmark by STADA Arzneimittel AG. The same ATC class is registered in 18 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Deferasirox is registered in 18 of 19 countries.
Countries holding a registration under ATC V03AC03 (deferasirox), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 10 of them publish a price we can compare per daily dose
Deferasirox · ATC V03AC03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of deferasirox costs, country by country.
Normalised to the WHO defined daily dose (0.98 g), the median price runs from $24.11 in Spain to $59.57 in Switzerland — a ×2.5 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Deferasirox · price per daily dose (0.98 g)
USD · FX 28 Sept 2026
- CH Switzerland$59.57
- IT Italy$43.21
- FR France$27.16
- ES Spain$24.11
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Deferasirox
- Manufacturer
- STADA Arzneimittel AG
- Country
- Denmark (DK)
- ATC code
- V03AC03
- ATC class
- Deferasirox
- Defined daily dose
- 0.98 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106138318
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
616 interactions on record for deferasirox.
Graded by severity as the source publishes them — 205 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Deferasirox · interactions on record
616 records
- 205 severe
- 399 moderate
- 12 minor
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Amphotericin BA07AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V03AC03
Deferasirox, as other registers publish it.
- CanadaAPO-DEFERASIROXAPOTEX INC
- CanadaAPO-DEFERASIROXAPOTEX INC
- CanadaAPO-DEFERASIROXAPOTEX INC
- CanadaAPO-DEFERASIROX (TYPE J)APOTEX INC
- CanadaAPO-DEFERASIROX (TYPE J)APOTEX INC
- CanadaAPO-DEFERASIROX (TYPE J)APOTEX INC
- CanadaAURO-DEFERASIROX (TYPE J)AURO PHARMA INC
- CanadaAURO-DEFERASIROX (TYPE J)AURO PHARMA INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eaf4bd80-8413-4dd5-abbd-1cf40cc54bc9 GET /v1/drugs/eaf4bd80-8413-4dd5-abbd-1cf40cc54bc9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "180 mg",
"auth_role": "CMS",
"dk_drugid": "28106138318",
"substance": "Deferasirox",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "43902"
}See everything about deferasirox.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.